Provided by Tiger Trade Technology Pte. Ltd.

Sagimet Biosciences Inc.

8.93
+0.01000.11%
Post-market: 8.90-0.0300-0.34%19:30 EDT
Volume:763.53K
Turnover:6.81M
Market Cap:633.21M
PE:-7.15
High:9.05
Open:8.84
Low:8.78
Close:8.92
52wk High:11.45
52wk Low:4.50
Shares:70.91M
Float Shares:67.62M
Volume Ratio:0.64
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2490
EPS(LYR):-1.5800
ROE:-24.37%
ROA:-16.41%
PB:2.47
PE(LYR):-5.65

Loading ...

Sagimet Says Partner Trial Shows Denifanstat Sustains Acne Efficacy Through 52 Weeks

Reuters
·
Oct 09

Sagimet Biosciences Price Target Maintained with a $29.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 05

Sagimet Biosciences price target raised to $26 from $25 at Guggenheim

TIPRANKS
·
Oct 02

Sagimet Biosciences Closes Offering of Shares, Warrants

MT Newswires Live
·
Oct 02

Sagimet Biosciences Announces Closing of Underwritten Offering of Series a Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Oct 02

Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

GlobeNewswire
·
Oct 02

Sagimet Biosciences Phase 3 Trial of Denifanstat as Acne Treatment Has High Success Probability, Wedbush Says

MT Newswires Live
·
Oct 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Sagimet Biosciences, Inc. Class A (SGMT) and Eli Lilly & Co (LLY)

TIPRANKS
·
Oct 01

Oppenheimer Adjusts Price Target on Sagimet Biosciences to $38 From $33, Maintains Outperform Rating

MT Newswires Live
·
Oct 01

Sagimet Biosciences Inc. : Oppenheimer Raises Target Price to $38 from $33

THOMSON REUTERS
·
Oct 01

Sagimet Biosciences Announces Major Equity Financing Agreement

TIPRANKS
·
Oct 01

Sagimet Biosciences’ China data strengthens denifanstat case, says Clear Street

TIPRANKS
·
Oct 01

Sagimet Prices $115 Million Offering of Series A Shares, Warrants; Shares Rise Pre-Bell

MT Newswires Live
·
Sep 30

Sagimet Biosciences prices 8.75M shares at $10.00 in underwritten offering

TIPRANKS
·
Sep 30

Sagimet Biosciences - Prices 8.8 Mln Series a Common Shares at $10 Per Share

THOMSON REUTERS
·
Sep 30

Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series a Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Sep 30

Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

GlobeNewswire
·
Sep 30

Sagimet Biosciences - Suspends and Terminates ATM Prospectus Supplement for Series a Common Stock Effective Sept 30

Reuters
·
Sep 30

Sagimet Biosciences - Suspends and Terminates Atm Prospectus Supplement for Series a Common Stock Effective Sept 30 - SEC Filing

THOMSON REUTERS
·
Sep 30

Sagimet Biosciences reports results from Phase 3 ASC40-304 OLE clinical trial

TIPRANKS
·
Sep 30